• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌免疫生物学的异质性。

Heterogeneity of Cholangiocarcinoma Immune Biology.

机构信息

School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.

Department of Oncology, University of Turin, 10043 Turin, Italy.

出版信息

Cells. 2023 Mar 8;12(6):846. doi: 10.3390/cells12060846.

DOI:10.3390/cells12060846
PMID:36980187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10047186/
Abstract

Cholangiocarcinomas (CCAs) are aggressive tumors arising along the biliary tract epithelium, whose incidence and mortality are increasing. CCAs are highly desmoplastic cancers characterized by a dense tumor microenvironment (TME), in which each single component plays a fundamental role in shaping CCA initiation, progression and resistance to therapies. The crosstalk between cancer cells and TME can affect the recruitment, infiltration and differentiation of immune cells. According to the stage of the disease and to intra- and inter-patient heterogeneity, TME may contribute to either protumoral or antitumoral activities. Therefore, a better understanding of the effect of each immune cell subtype may open the path to new personalized immune therapeutic strategies for the management of CCA. In this review, we describe the role of immune cells in CCA initiation and progression, and their crosstalk with both cancer-associated fibroblasts (CAFs) and the cancer-stem-cell-like (CSC) niche.

摘要

胆管癌(CCA)是一种起源于胆管上皮的侵袭性肿瘤,其发病率和死亡率正在上升。CCA 是一种高度促结缔组织增生性癌症,其特征是肿瘤微环境(TME)致密,其中每个单一成分在塑造 CCA 的发生、进展和对治疗的耐药性方面都起着至关重要的作用。癌细胞与 TME 之间的串扰会影响免疫细胞的募集、浸润和分化。根据疾病的阶段以及患者内和患者间的异质性,TME 可能有助于促进肿瘤或抗肿瘤活性。因此,更好地了解每种免疫细胞亚型的作用可能为管理 CCA 开辟新的个性化免疫治疗策略的道路。在这篇综述中,我们描述了免疫细胞在 CCA 的发生和进展中的作用,以及它们与癌相关成纤维细胞(CAF)和癌症干细胞样(CSC)龛之间的串扰。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/2c8b2ef6212f/cells-12-00846-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/ce5d41a5501b/cells-12-00846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/a461579cd898/cells-12-00846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/3e7ebc8136a0/cells-12-00846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/ed3141e578c4/cells-12-00846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/c599b024d2ea/cells-12-00846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/2c8b2ef6212f/cells-12-00846-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/ce5d41a5501b/cells-12-00846-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/a461579cd898/cells-12-00846-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/3e7ebc8136a0/cells-12-00846-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/ed3141e578c4/cells-12-00846-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/c599b024d2ea/cells-12-00846-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22ec/10047186/2c8b2ef6212f/cells-12-00846-g006.jpg

相似文献

1
Heterogeneity of Cholangiocarcinoma Immune Biology.胆管癌免疫生物学的异质性。
Cells. 2023 Mar 8;12(6):846. doi: 10.3390/cells12060846.
2
Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?胆管癌:最有价值的治疗靶点是什么——癌相关成纤维细胞、免疫细胞,还是 T 细胞以外的细胞?
Expert Opin Ther Targets. 2021 Oct;25(10):835-845. doi: 10.1080/14728222.2021.2010046. Epub 2021 Dec 3.
3
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.胆管癌中微环境和干细胞样可塑性的影响:分子网络和生物学概念。
J Hepatol. 2015 Jan;62(1):198-207. doi: 10.1016/j.jhep.2014.09.007. Epub 2014 Sep 16.
4
Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.靶向胆管癌的肿瘤微环境:治疗意义。
Expert Opin Investig Drugs. 2021 Apr;30(4):429-438. doi: 10.1080/13543784.2021.1865308. Epub 2020 Dec 28.
5
Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.肝内胆管癌进展和治疗耐药中的癌症相关成纤维细胞
Adv Cancer Res. 2022;156:201-226. doi: 10.1016/bs.acr.2022.01.009. Epub 2022 Feb 24.
6
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review).肿瘤免疫微环境与胆管癌的当前免疫治疗(综述)。
Int J Oncol. 2023 Dec;63(6). doi: 10.3892/ijo.2023.5585. Epub 2023 Oct 27.
7
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.胆管癌肿瘤微环境及其对抗肿瘤免疫的影响:新型治疗方法的未来展望。
Int J Biol Sci. 2022 Aug 21;18(14):5369-5390. doi: 10.7150/ijbs.73949. eCollection 2022.
8
Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma.解析胆管癌分子发病机制、起源细胞和干细胞特性的实验模型。
Liver Int. 2019 May;39 Suppl 1:79-97. doi: 10.1111/liv.14094.
9
The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of Cholangiocarcinoma.肿瘤免疫微环境在推动胆管癌进展中起着关键作用。
Curr Cancer Drug Targets. 2024;24(7):681-700. doi: 10.2174/0115680096267791231115101107.
10
Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.与纤维化基质微环境相关的慢性胆管损伤在p53基因缺陷小鼠中引发胆管癌。
Cancer Res. 2006 Jul 1;66(13):6622-7. doi: 10.1158/0008-5472.CAN-05-4609.

引用本文的文献

1
Role, mechanism, and application of N6-methyladenosine in hepatobiliary carcinoma.N6-甲基腺苷在肝胆癌中的作用、机制及应用
World J Gastrointest Oncol. 2025 Jun 15;17(6):105140. doi: 10.4251/wjgo.v17.i6.105140.
2
PPIH is a novel diagnostic biomarker associated with immune infiltration in cholangiocarcinoma.PPIH是一种与胆管癌免疫浸润相关的新型诊断生物标志物。
BMC Cancer. 2025 Feb 7;25(1):218. doi: 10.1186/s12885-025-13607-0.
3
Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights.

本文引用的文献

1
Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis.循环单核细胞与人类胆道癌抗 PD-1 耐药相关,可诱导 T 细胞衰竭。
Cell Rep. 2022 Sep 20;40(12):111384. doi: 10.1016/j.celrep.2022.111384.
2
Advances of cancer-associated fibroblasts in liver cancer.肝癌中癌相关成纤维细胞的研究进展
Biomark Res. 2022 Aug 16;10(1):59. doi: 10.1186/s40364-022-00406-z.
3
Genistein Sensitizes Human Cholangiocarcinoma Cell Lines to Be Susceptible to Natural Killer Cells.金雀异黄素使人类胆管癌细胞系对自然杀伤细胞敏感。
靶向实体癌中的分泌自噬:机制、免疫调节及临床见解
Exp Hematol Oncol. 2025 Feb 1;14(1):12. doi: 10.1186/s40164-025-00603-0.
4
Stroma-tology: Predicting recurrence in cholangiocarcinoma: Editorial on "Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma".间质学:预测胆管癌复发:关于“用于预测肝内胆管癌预后的间质-免疫特征的开发与验证”的社论
Clin Mol Hepatol. 2025 Jan;31(1):323-326. doi: 10.3350/cmh.2024.0932. Epub 2024 Oct 29.
5
Prognostic impact of the tumour microenvironment in intrahepatic cholangiocarcinoma: identification of a peritumoural fibro-immune interface.肿瘤微环境对肝内胆管癌预后的影响:肿瘤周围纤维免疫界面的鉴定。
Virchows Arch. 2024 Nov;485(5):901-911. doi: 10.1007/s00428-024-03922-5. Epub 2024 Sep 6.
6
Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions.治疗胆管癌冷肿瘤的策略:核心概念和未来方向。
Clin Exp Med. 2024 Aug 14;24(1):193. doi: 10.1007/s10238-024-01460-7.
7
Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome.肝外胆管癌:与解剖位置和预后相关的基因组变量。
JCO Precis Oncol. 2024 Jul;8:e2400206. doi: 10.1200/PO.24.00206.
8
From mechanism to therapy: the journey of CD24 in cancer.从机制到治疗:CD24 在癌症中的作用。
Front Immunol. 2024 May 31;15:1401528. doi: 10.3389/fimmu.2024.1401528. eCollection 2024.
9
SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment.丝氨酸蛋白酶抑制剂 1(SERPINE1):在胆管癌进展中的作用及其在纤维母细胞性微环境中的治疗靶点。
Cells. 2024 May 7;13(10):796. doi: 10.3390/cells13100796.
10
Efficacy and biomarker analysis of second-line nab-paclitaxel plus sintilimab in patients with advanced biliary tract cancer.二线纳武利尤单抗联合白蛋白紫杉醇治疗晚期胆道癌的疗效及生物标志物分析。
Cancer Sci. 2024 Jul;115(7):2371-2383. doi: 10.1111/cas.16179. Epub 2024 Apr 18.
Biology (Basel). 2022 Jul 23;11(8):1098. doi: 10.3390/biology11081098.
4
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target.肝内胆管癌的多模态单细胞分析将高激活的调节性T细胞定义为潜在治疗靶点。
J Hepatol. 2022 Nov;77(5):1359-1372. doi: 10.1016/j.jhep.2022.05.043. Epub 2022 Jun 20.
5
Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study.帕博利珠单抗治疗微卫星高度不稳定或错配修复缺陷型癌症:来自 II 期 KEYNOTE-158 研究的更新分析。
Ann Oncol. 2022 Sep;33(9):929-938. doi: 10.1016/j.annonc.2022.05.519. Epub 2022 Jun 6.
6
Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma.调节性 T 细胞诱导抑制性免疫微环境并促进肝内胆管癌的淋巴结转移。
Br J Cancer. 2022 Sep;127(4):757-765. doi: 10.1038/s41416-022-01838-y. Epub 2022 May 21.
7
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation.LAG-3xPD-L1 双特异性抗体通过树突状细胞激活增强 T 细胞的抗肿瘤反应。
Mol Ther. 2022 Aug 3;30(8):2800-2816. doi: 10.1016/j.ymthe.2022.05.003. Epub 2022 May 6.
8
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.肿瘤浸润淋巴细胞在胆管癌中的作用。
J Exp Clin Cancer Res. 2022 Apr 7;41(1):127. doi: 10.1186/s13046-022-02340-2.
9
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses.免疫细胞图谱揭示胆管癌的不同肿瘤微环境和相关预后。
J Hematol Oncol. 2022 Mar 28;15(1):37. doi: 10.1186/s13045-022-01253-z.
10
The Functional Roles of Immune Cells in Primary Liver Cancer.免疫细胞在原发性肝癌中的功能作用
Am J Pathol. 2022 Jun;192(6):826-836. doi: 10.1016/j.ajpath.2022.02.004. Epub 2022 Mar 23.